🟢 Heron Therapeutics is trading 7.41% up in pre-market with no clear catalyst identified

Heron Therapeutics is trading 7.41% up now at $0.29, with no clear company-specific announcement or fresh catalyst explaining the rebound after falling 12.82% to $0.27 on September 21, 2026.

• Recent coverage highlights CINVANTI patent uncertainty, withdrawn 2026 guidance, and strategic-review risks; these developments predate September 22.
• Broader pre-market indexes are slightly mixed, offering no clear market-wide explanation.